重组大鼠MSLN/间皮蛋白(His标签) Rat MSLN/Mesothelin Protein
The protein has a predicted MW of 35.67 kDa. Due to glycosylation, the protein migrates to 45-55 kDa based on Bis-Tris PAGE result. Less than 1EU per μg by the LAL method. ELISA Data: …
MSLN Gene - GeneCards | MSLN Protein | MSLN Antibody
2024年12月25日 · MSLN (Mesothelin) is a Protein Coding gene. Diseases associated with MSLN include Benign Mesothelioma and Malignant Pleural Mesothelioma. Among its related …
Abstract 93: Soluble mesothelin acts as a signaling molecule
2022年6月15日 · Mesothelin (MSLN) is a cell surface glycoprotein that is expressed by most pancreatic ductal adenocarcinoma (PDAC) and is used as a target for anti-cancer therapy. …
MSLN：超越实体瘤的免疫治疗靶点 - 知乎 - 知乎专栏
MSLN的结构与功能. MSLN基因编码一种前蛋白，经蛋白水解后产生巨核细胞增强因子（megakaryocyte-potentiating factor，MPF）和间皮素（MSLN）两种蛋白产物。 MSLN基因 …
Mesothelin：癌症免疫治疗的后起之秀 研究热点|生物学前沿技术
2019年9月24日 · 为鼎力协助科研和药企人员针对Mesothelin（MSLN）的在肿瘤中的临床应用研究，CUSABIO推出MSLN活性蛋白（Code：CSB-MP015044HUc9），助力您在MSLN机制方 …
Multiple proteases are involved in mesothelin shedding by cancer …
2020年12月1日 · Mesothelin (MSLN) is a lineage restricted cell surface protein expressed in about 30% of human cancers and high MSLN expression is associated with poor survival in …
His Tag重组人MSLN/间皮素蛋白 Human MSLN/Mesothelin Protein
MSLN, CAK1, Mesothelin, MPF, MPFSMRP, SMR. Accession. Q13421-2. Source. HEK293 Cells-derived Human MSLN/Mesothelin Protein, Glu296-Asp580 with hFc tag at the C-terminal. …
Mesothelin promotes brain metastasis of non-small cell lung …
2024年4月4日 · Brain metastasis (BM) is common among cases of advanced non-small cell lung cancer (NSCLC) and is the leading cause of death for these patients. Mesothelin (MSLN), a …
生物素标记食蟹猴MSLN/间皮蛋白 (Cynomolgus MSLN…
Recombinant Biotinylated Cynomolgus MSLN/Mesothelin Protein is expressed from HEK293 Cells with His tag at the C-terminal. It contains Asp296-Gly580. The protein has a predicted …
明星靶点MSLN, 在ADC领域的研发进展医药新闻-ByDrug-一站式医 …
2024年8月8日 · 间皮素（Mesothelin，MSLN）是一个40 kDa的膜结合蛋白，通过糖基化磷脂酰肌醇锚定于细胞膜。 它的前体蛋白是一种长约71 kDa的糖蛋白，可以被蛋白酶分解为两部分， …